$511 Million is the total value of VR Adviser, LLC's 22 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 87.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRNS | Sell | MARINUS PHARMACEUTICALS INC | $15,329,000 | +5.4% | 1,192,883 | -79.2% | 3.00% | -13.9% |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -378,888 | -100.0% | -1.10% | – |
| ETNB | Exit | 89BIO INC | $0 | – | -291,140 | -100.0% | -1.39% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICSspons adr | $0 | – | -781,940 | -100.0% | -1.87% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCspons adr | $0 | – | -1,057,827 | -100.0% | -2.05% | – |
| NARI | Exit | INARI MEDICAL INC | $0 | – | -235,000 | -100.0% | -2.73% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -845,000 | -100.0% | -4.17% | – |
| VXRT | Exit | VAXART INC | $0 | – | -2,765,000 | -100.0% | -5.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.